Literature DB >> 11075984

Guillain - Barre' syndrome following recombinant hepatitis B vaccine and literature review.

S Sinsawaiwong1, P Thampanitchawong.   

Abstract

A 17 year-old woman developed progressive quadriparesis with bilateral facial diplegia after immunization with recombinant hepatitis B vaccine 3 days prior. Cerebrospinal fluid analysis revealed acellular fluid with high protein level. The electrodiagnosis was compatible with demyelinating polyneuropathy. Other potential causes of Guillain-Barre' syndrome (GBS) were ruled out. Her motor power gradually improved and returned to normal later. The temporal relationship between GBS and vaccination was suggestive of a vaccine-induced cause. Mechanisms of this very rare complication are proposed with a literature review.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11075984

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  5 in total

1.  Transient facial nerve paralysis (Bell's palsy) following administration of hepatitis B recombinant vaccine: a case report.

Authors:  R Paul; L F A Stassen
Journal:  Br Dent J       Date:  2014-01       Impact factor: 1.626

2.  Relative trends in hospitalizations and mortality among infants by the number of vaccine doses and age, based on the Vaccine Adverse Event Reporting System (VAERS), 1990-2010.

Authors:  G S Goldman; N Z Miller
Journal:  Hum Exp Toxicol       Date:  2012-04-24       Impact factor: 2.903

Review 3.  Vaccines and Guillain-Barré syndrome.

Authors:  Penina Haber; James Sejvar; Yann Mikaeloff; Frank DeStefano
Journal:  Drug Saf       Date:  2009       Impact factor: 5.228

Review 4.  Hepatitis B vaccination and associated oral manifestations: a non-systematic review of literature and case reports.

Authors:  B Tarakji; N Ashok; R Alakeel; Sn Azzeghaibi; A Umair; S Darwish; Rs Mahmoud; E Elkhatat
Journal:  Ann Med Health Sci Res       Date:  2014-11

5.  Bell's palsy as a possible complication of hepatitis B vaccination in a child.

Authors:  Handan Alp; Hüseyin Tan; Zerrin Orbak
Journal:  J Health Popul Nutr       Date:  2009-10       Impact factor: 2.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.